MedTrace Logo

Randomized Trial of Intranasal Versus Intravenous Naloxone in Level of Consciousness in Suspected Opioid Overdose

NCT01293058 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-02-10

No results posted yet for this study

Summary

The purpose of this study is to determine which route of administration is better for treatment of opioid overdosed patients

Conditions

  • Morphinan Opioid Overdose

Interventions

DRUG

Intranasal naloxone

spray naloxone, 0.4 mg/ each 4 minutes till increasing patient level of consciousness

DRUG

Intravenous

Amp naloxone, 0.4 mg / each 4 minutes till increasing patient level of consciousness

Sponsors & Collaborators

  • Isfahan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Nastaran Izadi, A.Professor · Isfahan University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01293058 on ClinicalTrials.gov